Literature DB >> 8525656

Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.

A W Lohse1, G Gerken, H Mohr, H F Löhr, U Treichel, H P Dienes, K H Meyer zum Büschenfelde.   

Abstract

An etiopathological link between hepatitis virus infection and autoimmune liver disease, in particular autoimmune hepatitis has been suggested. In some patients features of both viral and autoimmune disease are present. We have studied 352 patients with autoimmune liver disease and 507 patients with viral hepatitis for diagnostic characteristics as well as for evidence of an etiological connection. 38 of the 201 patients with hepatitis C (19%) and 42 of the 306 patients with hepatitis B (14%) had significant titres of autoantibodies (ANA, SMA or LKM). SLA autoantibodies were found exclusively in patients with autoimmune liver disease. LKM auto-antibody was found in only one of the 201 HCV patients. Evidence of past or present hepatitis B virus and past hepatitis A virus infection was most common in the hepatitis C virus patients and least common in autoimmune hepatitis. 28 of the 352 patients with autoimmune liver diseases tested positive in the second generation anti-HCV ELISA, but only five patients (two with autoimmune hepatitis, one with primary sclerosing cholangitis and two with primary biliary cirrhosis) were positive in confirmatory anti-HCV assays, and only in these could HCV-RNA be isolated. Autoimmune hepatitis patients had significantly higher transaminase, GLDH and IgG levels. HLA-B8, HLA-DR3 and HLA-DR4 were significantly more common in autoimmune hepatitis. Distinction between autoimmune liver disease and viral hepatitis C could be made reliably on clinical and laboratory grounds. Our data show that a link between hepatitis A, B, or C virus infection and autoimmune liver diseases is highly unlikely.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8525656

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  8 in total

1.  Hepatitis B and C in Pakistan: A community survey.

Authors:  Nismat Javed; Muhammad Hassan Nadeem; Haider Ghazanfar
Journal:  Cureus       Date:  2019-10-24

Review 2.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

Review 3.  Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate.

Authors:  H Bécheur; D Valla; M A Loriot; A Attar; F Bloch; J P Petite
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

4.  Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.

Authors:  M Baeres; J Herkel; A J Czaja; I Wies; S Kanzler; E L R Cancado; G Porta; M Nishioka; T Simon; C Daehnrich; W Schlumberger; P R Galle; A W Lohse
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 5.  Auto immune hepatitis.

Authors:  Nicole Mf van Gerven; Ynto S de Boer; Chris Jj Mulder; Carin Mj van Nieuwkerk; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

6.  Autoimmune hepatitis in children: experiences in a tertiary center.

Authors:  Seyed-Mohsen Dehghani; Mahmood Haghighat; Mohammad-Hadi Imanieh; Nasser Honar; Amir-Masoud Negarestani; Abdorrasoul Malekpour; Mehran Hakimzadeh; Naghi Dara
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

Review 7.  Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.

Authors:  Dirk Roggenbuck; Maria G Mytilinaiou; Sergey V Lapin; Dirk Reinhold; Karsten Conrad
Journal:  Auto Immun Highlights       Date:  2012-10-30

Review 8.  Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms.

Authors:  Claudia Sirbe; Gelu Simu; Iulia Szabo; Alina Grama; Tudor Lucian Pop
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.